COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)

COX-2 and Prostaglandin EP3/EP4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL12-CXCR4 Chemokine Systems

(2010) Hiroshi Katoh et al.   AMERICAN JOURNAL OF PATHOLOGY

Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma

(2009) T. Krejsgaard et al.   BLOOD

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY

Selective Cyclooxygenase-2 (COX-2) Inhibitors Used for Preventing or Regressing Cancer

(2009) Ricardo Pereira   Recent Patents on Anti-Cancer Drug Discovery

PGE2 induces COX-2 expression in podocytes via the EP4 receptor through a PKA-independent mechanism

(2008) Wissam H. Faour et al.   CELLULAR SIGNALLING

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

(2008) M. Bernard et al.   CURRENT PHARMACEUTICAL DESIGN

Celecoxib transiently inhibits cellular protein synthesis

(2007) Peter Pyrko et al.   BIOCHEMICAL PHARMACOLOGY